Dystrobrevin alpha (DTNA) Antibody - FFPE Validated

Protein Function

This antibody is suited for researchers who want to analyze Dystrobrevin alpha (DTNA) and relate it to cell-state biology. Dystrobrevin alpha is a structural protein that interfaces with actin, microtubules, or associated adaptors. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

Following Dystrobrevin alpha across perturbations can help separate expression effects from compartment shifts.

Experimental Applications

Drug perturbations that affect polymerization or contractility can shift distribution and complex formation. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

Many workflows benefit from tracking both signal intensity and compartment distribution, especially when the target participates in multi-protein assemblies.

Common experimental questions that benefit from target tracking include:

• remodeling after perturbation of polymerization or contractility
• association with junctional complexes or focal adhesions
• stress-fiber versus cortical distribution patterns

Workflow Perspective

For paraffin-embedded samples, fixation history and retrieval strategy matter; this option is aligned to those constraints. To keep comparisons consistent, align sample preparation steps and define a clear baseline for each series.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so Dystrobrevin alpha patterns can be compared across experiments without guesswork.

When interpreting Dystrobrevin alpha, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

Use the fixed-section variant when your project demands Dystrobrevin alpha (DTNA) readouts that respect preparation constraints.